Latest News for: China design center

Edit

Vastai Technologies Raises $77M for Data Center AI Chips

Engineering Times 12 May 2021
There are more and more enterprises in China wanting to have their own Internet Data Centers, Qian said, because they want to control their own hardware in order to optimize for their specific application ... Vastai Technologies has its major operations in China, with design centers in Shanghai and Beijing, plus an R&D center in Toronto, Canada.
Edit

China ramps up UAVs with Chengdu industrial park

Asiatimes 11 May 2021
Quoting the South China Morning Post, Zhongtian Feilong Intelligent Technology — the Xian-based drone maker’s multirole high-subsonic UAV could be used for precision strikes on key assets such as enemy command centers, military airstrips, and aircraft carriers. China’s YLC-48 is ...
Edit

China says debris from its long March rocket landed in ocean

Finger Lakes Times 09 May 2021
... Harvard-Smithsonian Center for Astrophysics in Cambridge, Massachusetts, because China will be using the rocket for its space station as well as other missions ... “For some reason, China when designing the Long March 5B said ‘We don’t really care, we’ll just do it the simple way’.”.
Edit

China's pairing assistance program gives impetus to the development of Xinjiang

People Daily 08 May 2021
Recently, over 6,000 residents in Yamansu Kyrgyz ethnic township, Uqturpan county, Aksu prefecture of Xinjiang, received an insurance policy from the command center of east China's Zhejiang province for providing pairing assistance for Xinjiang. The insurance policy was designed ...
Edit

Great buildings recall early spirit of endeavor

China Daily 06 May 2021
The 10 buildings expressed New China's capacity in politics, technology and culture, and the idea to promote a people-centered development model," said Xu Quansheng, chairman of the Beijing Institute of Architectural Design, speaking in March.
Edit

Former Moffitt Cancer Center CEO Alan List lands new job at N.C. firm

Tampa Bay Times 04 May 2021
Alan List, who resigned in 2019 as the head of Moffitt Cancer Center over questions about China’s involvement in American-funded research, has found a new job ... Moffitt Cancer Center shakeup. CEO and others resign over China ties ... Top Moffitt Cancer Center doctors failed to disclose payments from China, report says.
Edit

Galmed Announces Approval of IND Application in China for Aramchol for the Treatment of NASH ...

The Oneida Daily Dispatch 03 May 2021
China to Join Galmed's Phase 3 ARMOR Registrational Study for the Treatment of NASH & Fibrosis ... "In line with these considerations, the ARMOR study was designed as an MRCT in approximately 215 centers located in U.S., Europe, Latin America, Australia, and now China ... We look forward to rapidly initiating enrollment in China later in H2 2021.".
Edit

GlycoMimetics Reports Highlights and Financial Results for First Quarter 2021

Pharmiweb 03 May 2021
Apollomics, our exclusive collaborator for development and commercialization of uproleselan in Greater China, received Breakthrough Therapy Designation from the Center for Drug Evaluation of the China National Medical Products Administration in early January.
Edit

Takeda Announces U.S. FDA Grants Priority Review for New Drug Application for Mobocertinib (TAK-788) as a Treatment for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer

Pharmiweb 28 Apr 2021
In October 2020, mobocertinib was designated as a Breakthrough Therapy in China by the Center for Drug Evaluation (CDE) for locally advanced or metastatic NSCLC patients with EGFR Exon20 insertion mutations who have been previously treated with at least one prior systemic chemotherapy.
Edit

Forum for RCEP Economic and Trade Cooperation held in Qingdao

China.dot.org 27 Apr 2021
The High-level Forum for RCEP Economic and Trade Cooperation kicks off in east China's port city of Qingdao on April 25. [Photo by Xu Xiaoxuan/China.org.cn] ... During the two-day event, participants also visited Qingdao Beer Museum, Qingdao International Design Center, Qingdao Port and Qingdao AI International Lounge.
Edit

Takeda Announces U.S. FDA Grants Priority Review for New Drug Application for Mobocertinib (TAK-788) as ...

The Marshall News Messenger 27 Apr 2021
In October 2020, mobocertinib was designated as a Breakthrough Therapy in China by the Center for Drug Evaluation (CDE) for locally advanced or metastatic NSCLC patients with EGFR Exon20 insertion mutations who have been previously treated with at least one prior systemic chemotherapy.
Edit

GLOBALink | New jetliner production, test flight center completed in Jiangxi, China

Xinhua 26 Apr 2021
China's first domestically designed and built large aircraft production and test flight center has been completed in east China's Jiangxi Province on Saturday ... Designed with a ...
Edit

Experts seek origin of tiger that entered village

China Daily 26 Apr 2021
... Center of the Natural Forestry and Grassland Administration ... It was then sent to the China Hengdaohezi Feline Breeding Center in Mudanjiang on Saturday. "It will be put under a 45-day quarantine in a designated area at the center," said Liu Dan, the center's chief engineer.
Edit

Conference held promoting Beijing Design Week

China Daily 26 Apr 2021
The event itself will be held from Sept 23 to Oct 7 in multiple places in Beijing, including the Zhangjiawan Design Town, National Agricultural Exhibition Center and the China Millennium Monument.
Edit

Nirsevimab demonstrated protection against respiratory syncytial virus disease in healthy infants in Phase 3 trial

Pharmiweb 26 Apr 2021
Editor’s note. In January 2021, nirsevimab received the Promising Innovative Medicine (PIM) Designation from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) and was also granted the Breakthrough Therapy Designation (BTD) by the China Center ...

Most Viewed

×